Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Patients need to self-inject twice daily, which may prove inconvenient and hinder consistent use
Adherence is low Despite growing demand, adherence remains a costly challenge
GLP-1 receptor agonists are approved for weight management in non-diabetic adults who meet clinical criteria for overweight or obesity, under medical supervision.v No specific restrictions, but a balanced diet with adequate hydration helps reduce gastrointestinal side effects and enhances results
Two have regulatory histories worth knowing: BPI Labs received an FDA warning letter in March 2025, and Olympia Pharmaceuticals received an FDA Form 483 in May 2024
US$ 29.19
US$ 22.32
US$ 29.21
US$ 28.74
US$ 29.02
